 KANSAS CITY, Kan., June 17, 2022 GLOBE NEWSWIRE -- Cingulate Inc. NASDAQ: CING, a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed ReleaseTM PTRTM drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and Chief Executive Officer, Shane J. Schaffer, PharmD, will present a company overview at the Diamond Equity Research 2022 Virtual Emerging Growth Invitational on Thursday, June 23, 2022 at 1:40 PM EST. Following the presentation, Dr. Schaffer will take questions from participants. 